Global, Regional, and National burden of Parkinson's disease from 1990-2023: An Analysis of Trends, Inequalities, and Future Projections
Maqsood, K.; Fatima, M.; Naveed, H.; Afzal, W.; Ali Beg, Z.; Alhussain, F.; Saeed abualait, T.; Bashir, S.
Show abstract
BackgroundAmong the neurological disorders Parkinson deasease (PD) has emerged as one of the rapidly growing disorder, worldwide. This study is aimed to analyse the global, regional and national burden and trends of PD from 1990-2023, across the genders, age groups and sociodemographic context and forecasts of global trends through 2040. MethodsFor this study the data were sourced from the publically available most recent Global Burden of Disease (GBD) 1990-2023. The trends in age-standardized rates for key metrices including disability-adjusted life years (ASDR), mortality (ASMR), incidence (ASIR), and prevalence (ASPR) were analysed. Temporal trends were evaluated using estimated annual percentage changes (EAPCs). Associations with the Socio-Demographic Index (SDI) were explored using LOWESS regression. Future burden (2024-2040) was projected using an autoregressive integrated moving average (ARIMA) model. ResultsGlobally, the ASDR increased from 77.71 to 88.62 per 100,000, ASMR from 4.27 to 4.85, ASIR from 11.92 to 15.11, and ASPR from 93.76 to 128.46. In 2023, PD accounted for 11.67 million cases and 0.42 million deaths. The greatest DALY increases occurred in low-middle SDI regions (33.23%), while high-middle SDI regions showed mild declines, which was also endorsed by LOWESS analysis. Regionally, the highest ASDR growth occurred in High-income North America (EAPC = 1.54%) and Central Sub-Saharan Africa (EAPC = 1.04%), whereas East Asia and Oceania showed declines. Prevalence rose most in North Africa and the Middle East (+97.74%; EAPC = 2.00). Nationally, the burden reduced in Kuwait and Qatar but rose sharply in Maldives and Ethiopia. PD burden increased exponentially with age and was consistently higher among males. Forecasts suggest continued global increases by 2040. ConclusionsFrom 1990 to 2023, PD burden rose substantially worldwide, with the steepest increases in low- and middle-SDI regions. Despite stabilization in high-income areas, the global burden is projected to rise through 2040, underscoring the need for enhanced prevention, early diagnosis, and equitable access to long-term care.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- COVID19-related and all-cause mortality among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection in the region of Tarragona, Spain: results from the COVID19 TARRACO Cohort Study, March-June 2020 88%
- Variation in real world dementia risk profiles in 6171 adults drawn from the Australian CogDrisk website according to demographic characteristics 88%
- Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries 87%
Similar papers in this journal
- Projecting trends in the disease burden of adult edentulism in China between 2020 and 2030: a systematic study based on the global burden of disease 90%
- SARS-CoV-2 Seroprevalence and Risk Factors among Convalescents in Sichuan Province, China: a retrospective cohort study 89%
- Stay-at-home and face mask policies intentions inconsistent with incidence and fatality during US COVID-19 pandemic 89%
Similar papers in this journal
- The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi 90%
- The International Classification of Functioning, Disability and Health to map leprosy-related disability in rural and remote areas in Indonesia 89%
- Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection 89%
Similar papers in this journal
- A synthetic kinematic index of trunk displacement conveying the overall motor condition in Parkinson's disease 93%
- Developing and Validating a New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson's Disease 92%
- Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.